StockData
CareDx, Inc. logo

CareDx, Inc. (CDNA) stock

CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.44−0.12 (-0.16%)

Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –

CareDx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CareDx's free cash flow for the twelve months ending Sep 30, 2019 was -$1.62M. For fiscal 2018 it was -$6.04M. The highest annual figure on record is -$644.00K in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2018Dec 31, 2018-$6.04M–
FY2017Dec 31, 2017-$14.49M–
FY2016Dec 31, 2016-$17.07M–
FY2015Dec 31, 2015-$10.95M–
FY2014Dec 31, 2014-$4.08M–
FY2013Dec 31, 2013-$644.00K–
FY2012Dec 31, 2012-$1.92M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$11.10M+24.9%
Q2 FY2026Jun 30, 2026$28.75M–
Q1 FY2026Mar 31, 2026$514.00K–
Q3 FY2025Sep 30, 2025$36.05M+418.7%
Q2 FY2025Jun 30, 2025$8.89M–
Q1 FY2025Mar 31, 2025-$28.21M-1531.5%
Q3 FY2021Sep 30, 2021-$3.24M-114.5%
Q2 FY2021Jun 30, 2021$6.95M–
Q1 FY2021Mar 31, 2021-$34.88M-17895.9%
Q3 FY2020Sep 30, 2020$1.97M-44.6%
Q2 FY2020Jun 30, 2020$22.37M–
Q1 FY2020Mar 31, 2020-$4.76M-558.5%
Q3 FY2019Sep 30, 2019$196.00K–
Q2 FY2019Jun 30, 2019$3.56M–
Q1 FY2019Mar 31, 2019-$6.41M–
Q4 FY2018Dec 31, 2018$1.04M–
Q3 FY2018Sep 30, 2018-$215.00K–
Q2 FY2018Jun 30, 2018-$2.29M–
Q1 FY2018Mar 31, 2018-$4.58M–
Q4 FY2017Dec 31, 2017-$2.24M–
Q3 FY2017Sep 30, 2017-$2.23M–
Q2 FY2017Jun 30, 2017-$3.22M–
Q1 FY2017Mar 31, 2017-$6.81M–
Q4 FY2016Dec 31, 2016-$2.98M–

More CareDx figures

See a number that looks wrong?